Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Abstract Background Type 1 diabetes (T1D) results from immune-mediated destruction of insulin-producing beta cells. Prevention efforts have focused on immune modulation and supporting beta cell health before or around diagnosis; however, heterogeneity in disease progression and therapy response has...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jamie L. Felton, Kurt J. Griffin, Richard A. Oram, Cate Speake, S. Alice Long, Suna Onengut-Gumuscu, Stephen S. Rich, Gabriela S. F. Monaco, Carmella Evans-Molina, Linda A. DiMeglio, Heba M. Ismail, Andrea K. Steck, Dana Dabelea, Randi K. Johnson, Marzhan Urazbayeva, Stephen Gitelman, John M. Wentworth, Maria J. Redondo, Emily K. Sims, ADA/EASD PMDI
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2023-10-01
Colección:	Communications Medicine
Acceso en línea:	https://doi.org/10.1038/s43856-023-00357-y
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!